BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from −10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CBAT
CBAK Energy Technology, Inc.
There isn't enough reported data to score CBAT yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CBAT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Strong | |
| Weak |
CBAT's revenue and cash flow are currently strong, but its profitability and balance sheet are weak.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
CBAT PE Valuation
CBAT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 4.8x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
CBAT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CBAT to return to profit, with revenue growing.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CBAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.20 | — |
| Q1 2026 | -$0.18 | -$0.18 |
| Q4 2025 | -$0.10 | -177% |
| Q3 2025 | -$0.07 | -154% |
| Q2 2025 | -$0.10 | -150% |
| Q1 2025 | $0.00 | -100% |
| Q4 2024 | $0.13 | +$0.16 |
| Q3 2024 | $0.13 | +$0.23 |
| Q2 2024 | $0.20 | +$0.37 |
CBAT is still losing money, but less than at its worst: $0.18 per share over the past year, against $0.35 at its worst in late 2019.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
CBAT has the stronger quarterly revenue trend. Revenue is up 3.9% for BA versus up 99% for CBAT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CBAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $69.6M | +99% |
| Q4 2025 | $58.8M | +132% |
| Q3 2025 | $60.9M | +37% |
| Q2 2025 | $40.5M | -15% |
| Q1 2025 | $34.9M | -41% |
| Q4 2024 | $25.4M | -55% |
| Q3 2024 | $44.6M | -30% |
| Q2 2024 | $47.8M | +13% |
CBAT's revenue is growing: $70M last quarter, up 99% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -14% | -5.7 points |
| Q4 2025 | -14% | +12 points |
| Q3 2025 | -6.6% | -4.8 points |
| Q2 2025 | -8.7% | -21 points |
| Q1 2025 | -8.2% | -26 points |
| Q4 2024 | -26% | -16 points |
| Q3 2024 | -1.9% | -10 points |
| Q2 2024 | 12% | +21 points |
CBAT's operating margin was −14% last quarter, down 5.7 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
CBAT has the stronger cash trend. Its trailing FCF is up 6,165% versus its history, compared with BA at up 100%.
CBAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $10.5M | +$32.8M |
| Q4 2025 | $16.1M | +310% |
| Q3 2025 | $6M | -64% |
| Q2 2025 | $4.1M | +65% |
| Q1 2025 | -$22.3M | -$21.9M |
| Q4 2024 | $3.9M | -80% |
| Q3 2024 | $16.5M | +$17M |
| Q1 2024 | -$454K | -105% |
CBAT generated $37M in free cash flow over the past year, more than ten times what it generated the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CBAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.8% | -692K shares |
| 3 years | +0.3% | +234K shares |
| 5 years | +5.1% | +4.3M shares |
| Available history | +152% | +53.9M shares |
CBAT has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $263,111 |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CBAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 8.4x | High |
| Q4 2024 | 3.6x | Elevated |
| Q3 2024 | 2.9x | Moderate |
| Q2 2024 | -0.3x | Net Cash |
| Q1 2024 | 1.2x | Healthy |
| Q4 2023 | -1.8x | Net Cash |
CBAT's net debt is about 8.4 years of its operating earnings (EBITDA), up from 1.2 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CBAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 48.3 | Neutral |
CBAT's weekly RSI is 52 (neutral) and its Stochastic is 48 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
CBAT PE vs Industrials Sector
| Metric | CBAT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CBAT has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CBAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 11% below |
| 20 week MA | $0.88 | 9.1% above |
| 50 week MA | $0.85 | 13% above |
| 100 week MA | $0.89 | 7.9% above |
| 200 week MA | $0.97 | 1% below |
CBAT has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CBAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.14 | $6.26 | +449% |
| 2021 | $6.26 | $1.69 | -73% |
| 2022 | $1.69 | $0.98 | -42% |
| 2023 | $0.98 | $1.05 | +7.1% |
| 2024 | $1.05 | $1.07 | +1.9% |
| 2025 | $1.07 | $0.86 | -20% |
| 2026 YTD | $0.86 | $0.96 | +12% |
CBAT has the edge over BA on returns for 2026, with the stronger performance.